JP2004506676A5 - - Google Patents

Download PDF

Info

Publication number
JP2004506676A5
JP2004506676A5 JP2002520778A JP2002520778A JP2004506676A5 JP 2004506676 A5 JP2004506676 A5 JP 2004506676A5 JP 2002520778 A JP2002520778 A JP 2002520778A JP 2002520778 A JP2002520778 A JP 2002520778A JP 2004506676 A5 JP2004506676 A5 JP 2004506676A5
Authority
JP
Japan
Prior art keywords
dermatological
cosmetic
preparations
formulations
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002520778A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004506676A (ja
Filing date
Publication date
Priority claimed from DE2000140932 external-priority patent/DE10040932A1/de
Priority claimed from DE2000155706 external-priority patent/DE10055706A1/de
Application filed filed Critical
Priority claimed from PCT/EP2001/009446 external-priority patent/WO2002015868A2/de
Publication of JP2004506676A publication Critical patent/JP2004506676A/ja
Publication of JP2004506676A5 publication Critical patent/JP2004506676A5/ja
Pending legal-status Critical Current

Links

JP2002520778A 2000-08-18 2001-08-16 化粧品用調合物 Pending JP2004506676A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2000140932 DE10040932A1 (de) 2000-08-18 2000-08-18 Verwendung von Di-myo-inositolphosphat (DIP) und/oder Derivaten in kosmetischen und dermatologischen Formulierungen
DE2000155706 DE10055706A1 (de) 2000-08-22 2000-08-22 Verwendung von Di-Glycerinphosphat (DGP) und/oder Derivaten in kosmetischen und dermatologischen Formulierungen
PCT/EP2001/009446 WO2002015868A2 (de) 2000-08-18 2001-08-16 Kosmetische formulierung enthaltend mindestens ein di-zuckeralkoholphosphat von c3 bis c6 zuckeralkoholen

Publications (2)

Publication Number Publication Date
JP2004506676A JP2004506676A (ja) 2004-03-04
JP2004506676A5 true JP2004506676A5 (enExample) 2008-10-09

Family

ID=26006764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002520778A Pending JP2004506676A (ja) 2000-08-18 2001-08-16 化粧品用調合物

Country Status (8)

Country Link
US (1) US20040028631A1 (enExample)
EP (1) EP1311238B1 (enExample)
JP (1) JP2004506676A (enExample)
AT (1) ATE446083T1 (enExample)
AU (1) AU2001295469A1 (enExample)
DE (1) DE50115191D1 (enExample)
ES (1) ES2336545T3 (enExample)
WO (1) WO2002015868A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10330243A1 (de) * 2003-07-03 2005-01-20 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis
JP2008537734A (ja) * 2005-03-12 2008-09-25 ビトップ アクツィエンゲゼルシャフト フュール ビオテヒニシェ オプティミールング 経口で用いられる適合溶質を含む薬剤
US7666494B2 (en) * 2005-05-04 2010-02-23 3M Innovative Properties Company Microporous article having metallic nanoparticle coating
CN101282708B (zh) * 2005-10-05 2013-03-20 江崎格力高株式会社 含有磷酸化糖的皮肤外用剂
DE102007040615A1 (de) * 2007-08-27 2009-03-05 Bitop Ag Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen
US20090155194A1 (en) * 2007-12-18 2009-06-18 Schering-Plough Healthcare Products, Inc. Enhanced photostability of avobenzone in the presence of zinc oxide using phosphate-based emulsifiers
JP2009203192A (ja) * 2008-02-28 2009-09-10 Kose Corp インボルクリン産生促進剤、及び肌荒れ防止又は改善用皮膚外用剤
JP5198899B2 (ja) * 2008-02-28 2013-05-15 株式会社コーセー 細胞賦活剤及び老化防止用皮膚外用剤
DE102008039231A1 (de) * 2008-08-22 2010-02-25 Bitop Ag Verwendung von Glucosylglycerol
US10463891B2 (en) 2008-09-30 2019-11-05 Symrise Ag Extracts of Isochrysis sp.
EP3348255B1 (en) 2008-12-05 2021-11-10 Symrise AG Extracts of tetraselmis sp. for cosmetic and therapeutic purposes
KR101676375B1 (ko) 2009-04-09 2016-11-15 시므라이즈 아게 피부 자극-완화제로서 트랜스-텔트-부틸 사이클로헥사놀을 포함하는 조성물
BRPI0924661B1 (pt) 2009-04-28 2018-12-11 Symrise Ag Ômega-ciclo-hexilalcan-1-óis, seus métodos de produção, suas composições, suas formulações cosméticas, uso dos mesmos como ativos microbianos e método parareduzir a taxa de crescimento de corynebacterium xerosis e/ou staphylococcus epidermidis e/ou brevibacterium epidermidis
BR112012025740B1 (pt) 2010-04-08 2017-12-26 Symrise Ag Cosmetic preparation, and use of dihydrodesidrodi-isoeugenol
EP2389922A1 (en) 2010-05-25 2011-11-30 Symrise AG Cyclohexyl carbamate compounds as anti-ageing actives
MY170724A (en) 2012-01-27 2019-08-27 Biotropics Malaysia Berhad Use of certain trioxygenated benzene derivatives in body fat management
US20160008297A1 (en) 2012-08-23 2016-01-14 B.R.A.I.N. Biotechnology Research And Information Network Ag Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
JP2019510037A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド 抗菌ペプチド刺激性洗浄組成物
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
AU2017240069B2 (en) 2016-03-31 2024-03-07 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2018041354A1 (en) 2016-09-01 2018-03-08 Symrise Ag Product comprising a plastic container and a substance composition
WO2018098152A1 (en) 2016-11-23 2018-05-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
EP3733076B1 (en) * 2017-12-28 2024-08-28 Kao Corporation Method for determining ultraviolet light sensitivity
WO2018154145A2 (en) 2018-03-29 2018-08-30 Symrise Ag Compounds for skin improvement / treatment
WO2022129101A1 (en) 2020-12-14 2022-06-23 Symrise Ag Extracts of isochrysis species / tisochrysis species
WO2022128164A1 (en) 2020-12-14 2022-06-23 Symrise Ag Extracts of isochrysis species / tisochrysis species
US20240335364A1 (en) 2021-07-23 2024-10-10 Symrise Ag Compositions of dicaffeoylquinic acids with tocopherol

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8605063D0 (sv) * 1986-11-26 1986-11-26 Matti Siren Derivatives of cyclohexane
JPS6416890A (en) * 1987-07-10 1989-01-20 Shiseido Co Ltd Antioxidant
US4861795A (en) * 1988-06-23 1989-08-29 Rorer Pharmaceutical Corporation Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
KR950007045B1 (ko) * 1992-04-14 1995-06-30 주식회사태평양 폴리에톡실레이티드 비타민 e를 함유한 피부화장료
US5428063A (en) * 1994-04-11 1995-06-27 Board Of Regents Of The University Of Nebraska Use of betaine as a hepatic generator of S-adenosylmethionine and as a protective agent against hepatotoxicity
FR2728793A1 (fr) * 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
US5560917A (en) * 1995-02-01 1996-10-01 Maybelline Intermediate Company Cosmetic makeup composition
PT101813B (pt) * 1996-01-11 1998-12-31 Inst De Biolog Ex E Tecnologic Utilizacao de fosfato de di-manosil-di-mio-inositol e de fosfato de 1,3-di-mio--inositol na termoestabilizacao, osmoproteccao e proteccao contra a desidratacao de componentes celulares e celulas
FR2749303B1 (fr) * 1996-05-30 1998-08-07 Berkem Sa Procede d'extraction de polyphenols catechiques a partir de potentilles extrait obtenu et son utilisation
US6264879B1 (en) * 1996-06-05 2001-07-24 Mat, Inc. Reconstituted leather product and process
US5961990A (en) * 1997-05-02 1999-10-05 Kobo Products S.A.R.L. Cosmetic particulate gel delivery system and method of preparing complex gel particles
US5916576A (en) * 1997-05-30 1999-06-29 Amway Corporation Method of scavenging free radicals using orange extract
DE19737327A1 (de) * 1997-08-27 1999-03-04 Haarmann & Reimer Gmbh Hydroxyzimtsäureamide hydroxysubstituierter aromatischer Amine
ES2195298T3 (es) * 1998-04-08 2003-12-01 Bitop Ag Fur Biotechnische Opt Termoestabilizacion, osmoproteccion y proteccion contra la desecacion de enzimas, componentes celulares y celulas por di-glicerol-fosfato.
FR2780647B1 (fr) * 1998-07-03 2002-03-08 Lanatech Composition cosmetique exploitant des effets antiradicalaires synergiques
FR2780879B1 (fr) * 1998-07-09 2002-09-20 Oreal Composition cosmetique photoprotectrice contenant un tensio-actif anionique, un compose filtrant le rayonnement ultraviolet et un compose cationique ou zwitterionique amphiphile et son utilisation
EP1124815B1 (de) * 1998-10-30 2004-05-26 MERCK PATENT GmbH Verfahren zur herstellung von luteolin und luteolin-derivaten
FR2785802B1 (fr) * 1998-11-12 2002-10-31 Oreal 2-amino, 4-alkylamino pyrimidine 3-oxydes comme anti-inflammatoires
DE19903241A1 (de) * 1999-01-28 2000-08-03 Merck Patent Gmbh Galenische Formulierung
EP1029849A1 (de) * 1999-02-19 2000-08-23 Haarmann & Reimer Gmbh Hydroxymandelsäureamide phenolischer Amine
JP2003501479A (ja) * 1999-06-12 2003-01-14 ビトプ ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬 剤
EP1125583A1 (de) * 2000-02-14 2001-08-22 Bitop Gesellschaft für biotechnische Optimierung MbH Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren
ES2233630T3 (es) * 2000-04-12 2005-06-16 Bitop Aktiengesellschaft Fur Biotechnische Optimierung Uso de solutos compatibles como sustancias con propiedades barredoras de radicales.
US6485950B1 (en) * 2000-07-14 2002-11-26 Council Of Scientific And Industrial Research Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions
FR2826264B1 (fr) * 2001-06-26 2005-03-04 Oreal Solubilisation de derives 1,3,5 triazine par des esters n-acyles d'acide amine
FR2827511B1 (fr) * 2001-07-19 2003-10-17 Oreal Composition autobronzante contenant un ester n-acyle d'acide amine et un agent autobronzant
FR2830773B1 (fr) * 2001-10-11 2004-07-23 Oreal Utilisation de copolymeres amphiphiles pour stabiliser des dispersions de composes organiques insolubles filtrant le rayonnement uv, dispersions stabilisees par ces copolymeres et compositions cosmetiques les contenant

Similar Documents

Publication Publication Date Title
AU2001230892A1 (en) Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same
BE2011C013I2 (enExample)
DZ3358A1 (fr) Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression
EP1435894A4 (en) CYTOPROTECTIVE COMPOUNDS, PHARMACEUTICAL AND COSMETIC FORMULATIONS AND METHOD
MA27107A1 (fr) Formulations aerosoles pour l'administration pulmonaire de medicaments visant a produire un effet systemique.
WO2008061226A3 (en) Sustained-release formulations of topiramate
AU2002357012A1 (en) Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
AU2003229555A1 (en) Oral administration form for difficulty soluble basic active ingredients which are applied orally
GB0100758D0 (en) Immunogenic complex method of preparation thereof and pharmaceutical compositions containing the same, useful for disease control
CA2386690A1 (en) Pharmaceutical tramadol salts
DE60235719D1 (de) Frauenhygieneartikel zur verabreichung von arzneimittel
WO2001038303A3 (fr) Analogues de la vitamine d
AU2108500A (en) Galenic formulation containing biotin
WO2003028715A3 (en) Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis
WO2003072030A3 (en) Methods for preventing or treating cardiac arrhythmia
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
AU6571400A (en) Pharmaceutical formulation comprising amoxycillin and clavulanate
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
WO2001080891A8 (en) Remedies for interstitial pneumonia, method of constructing animal model of this disease and screening method with the use of the same
WO1996029065A3 (en) Aminotetralin derivative for the therapy of cardiovascular diseases
CA2376847A1 (en) Complex of eletriptan and a cyclodextrin derivative
EP1245562A4 (en) ALCOHOLS 5-THIA- "OMEGA" - (PHENYL SUBSTITUTED) - PROSTAGLANDIN E, PROCESS FOR THE PREPARATION OF SUCH ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE ALCOHOLS AS ACTIVE INGREDIENT.
WO2004030684A3 (en) Kavalactone product
CA2387600A1 (en) Novel fusidic acid derivatives